The HemOnc Pulse Part One: The Question of MRD in CLL Therapy
4 snips
Jul 18, 2024 The podcast features experts in CLL therapy discussing topics like the impact of MRD, comparative analysis of BTK inhibitors, challenges in defining cure, selecting BTKIs in frontline therapy, and optimizing treatment strategies for young CLL patients. They debate on therapy duration, patient outcomes, and future approaches in treating high-risk CLL patients.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Exploring the Impact of MRD in CLL Therapy
01:32 • 15min
Comparative Analysis of BTK Inhibitors for CLL Therapy and Treatment Options
16:07 • 2min
Challenges in Defining Cure and Treating High-risk Patients in CLL Therapy
18:10 • 10min
Exploring the Selection of BTKIs in Frontline Therapy
27:56 • 2min
Optimizing Treatment Strategies for Young CLL Patients
30:20 • 5min